GlassScriptPhysician profile
Tracy Graebener
NPI 1114399706
$28,548.88
in general payments reported to CMS, 2019-2025
17 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $2,178 · 2023: $3,778 · 2024: $10K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $23K · Travel and Lodging: $2,006 · Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $22,766.66 |
| Travel and Lodging | $2,005.51 |
| Food and Beverage | $1,308.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22,787.25 | 2023-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medtronic, INC. | $1,865.80 | 2023-2024 | Venaseal |
| Bard Peripheral Vascular, INC. | $1,746.82 | 2022-2024 | |
| Boston Scientific Corporation | $725.72 | 2023-2024 | Varithena Administration Pack, Wavewriter Alpha Prime 16, Watchman Access System |
| Inspire Medical Systems, INC. | $320.82 | 2022-2023 | Inspire |
| Optinose US, INC. | $215.34 | 2021-2022 | |
| Glaxosmithkline, LLC. | $180.71 | 2024-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $150.75 | 2021-2024 | Dupixent |
| Genzyme Corporation | $129.03 | 2021-2024 | |
| Stryker Corporation | $100.45 | 2023-2024 | Scopis Ent, Xpress Ent Dilation System |
| Acclarent, INC | $84.33 | 2022 | |
| Corcept Therapeutics | $57.48 | 2025 | Korlym |
| Smith+Nephew, INC. | $49.58 | 2025 | Tula, Halo, Ent Sinus |
| Phathom Pharmaceuticals, INC. | $45.12 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $35.28 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $27.56 | 2021 | |
| Integra Lifesciences Corporation | $26.84 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Graebener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.